Brookmont Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.16M Sell
37,551
-940
-2% -$104K 2.39% 9
2025
Q1
$4.31M Sell
38,491
-12,592
-25% -$1.41M 2.43% 8
2024
Q4
$4.72M Buy
51,083
+7,322
+17% +$676K 2.52% 8
2024
Q3
$3.67M Sell
43,761
-1,435
-3% -$120K 1.89% 16
2024
Q2
$3.1M Sell
45,196
-1,488
-3% -$102K 1.7% 21
2024
Q1
$3.42M Buy
46,684
+1,005
+2% +$73.6K 1.8% 20
2023
Q4
$3.7M Sell
45,679
-812
-2% -$65.8K 2.07% 16
2023
Q3
$3.48M Sell
46,491
-326
-0.7% -$24.4K 2.17% 16
2023
Q2
$3.61M Buy
46,817
+25
+0.1% +$1.93K 2.18% 16
2023
Q1
$3.88M Buy
46,792
+212
+0.5% +$17.6K 2.44% 11
2022
Q4
$4M Buy
46,580
+17,238
+59% +$1.48M 2.46% 9
2022
Q3
$1.81M Buy
29,342
+2,346
+9% +$145K 1.26% 30
2022
Q2
$1.67M Buy
26,996
+351
+1% +$21.7K 1.15% 30
2022
Q1
$1.58M Buy
26,645
+571
+2% +$33.9K 0.95% 32
2021
Q4
$1.89M Sell
26,074
-1,104
-4% -$80.2K 1% 30
2021
Q3
$1.9M Buy
27,178
+514
+2% +$35.9K 1.12% 31
2021
Q2
$1.84M Buy
26,664
+18
+0.1% +$1.24K 1.11% 30
2021
Q1
$1.72M Buy
26,646
+180
+0.7% +$11.6K 1.11% 30
2020
Q4
$1.54M Sell
26,466
-1,670
-6% -$97.3K 1.09% 29
2020
Q3
$1.78M Buy
28,136
+518
+2% +$32.7K 1.32% 24
2020
Q2
$2.13M Sell
27,618
-11,164
-29% -$859K 1.7% 22
2020
Q1
$2.9M Buy
38,782
+3,225
+9% +$241K 2.34% 11
2019
Q4
$2.31M Sell
35,557
-2,940
-8% -$191K 1.38% 28
2019
Q3
$2.44M Sell
38,497
-125
-0.3% -$7.92K 1.39% 28
2019
Q2
$2.61M Buy
38,622
+195
+0.5% +$13.2K 1.57% 25
2019
Q1
$2.5M Buy
38,427
+81
+0.2% +$5.27K 1.54% 26
2018
Q4
$2.4M Buy
38,346
+451
+1% +$28.2K 1.63% 28
2018
Q3
$2.93M Buy
37,895
+41
+0.1% +$3.17K 1.74% 23
2018
Q2
$2.68M Buy
37,854
+4,327
+13% +$307K 1.69% 25
2018
Q1
$2.53M Sell
33,527
-31,387
-48% -$2.37M 1.67% 26
2017
Q4
$4.65M Buy
64,914
+21,628
+50% +$1.55M 2% 29
2017
Q3
$3.51M Buy
43,286
+51
+0.1% +$4.13K 1.92% 26
2017
Q2
$3.06M Buy
43,235
+5,154
+14% +$365K 1.15% 30
2017
Q1
$2.59M Buy
+38,081
New +$2.59M 0.96% 32